These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 8242228)
1. Characteristics of the binding of [3H]-GR32191 to the thromboxane (TP-) receptor of human platelets. Armstrong RA; Humphrey PP; Lumley P Br J Pharmacol; 1993 Oct; 110(2):539-47. PubMed ID: 8242228 [TBL] [Abstract][Full Text] [Related]
2. Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191. Armstrong RA; Humphrey PP; Lumley P Br J Pharmacol; 1993 Oct; 110(2):548-52. PubMed ID: 8242229 [TBL] [Abstract][Full Text] [Related]
3. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro. Lumley P; White BP; Humphrey PP Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074 [TBL] [Abstract][Full Text] [Related]
4. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes. Parent CA; Lagarde M; Venton DL; Le Breton GC J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390 [TBL] [Abstract][Full Text] [Related]
5. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
6. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists. Hanasaki K; Arita H Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322 [TBL] [Abstract][Full Text] [Related]
8. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe. Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474 [TBL] [Abstract][Full Text] [Related]
9. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145. Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873 [TBL] [Abstract][Full Text] [Related]
10. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. Hanasaki K; Nagasaki T; Arita H Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906 [TBL] [Abstract][Full Text] [Related]
11. Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets. Hedberg A; Hall SE; Ogletree ML; Harris DN; Liu EC J Pharmacol Exp Ther; 1988 Jun; 245(3):786-92. PubMed ID: 2968449 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements. Tymkewycz PM; Jones RL; Wilson NH; Marr CG Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826 [TBL] [Abstract][Full Text] [Related]
13. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems. Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029 [TBL] [Abstract][Full Text] [Related]
14. Binding of a thromboxane A2/prostaglandin H2 agonist [3H]U46619 to washed human platelets. Liel N; Mais DE; Halushka PV Prostaglandins; 1987 Jun; 33(6):789-97. PubMed ID: 2959986 [TBL] [Abstract][Full Text] [Related]
15. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Theis JG; Dellweg H; Perzborn E; Gross R Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312 [TBL] [Abstract][Full Text] [Related]
16. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). Kattelman EJ; Venton DL; Le Breton GC Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368 [TBL] [Abstract][Full Text] [Related]
17. DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors. Liu EC; Hedberg A; Goldenberg HJ; Harris DN; Webb ML Prostaglandins; 1992 Aug; 44(2):89-99. PubMed ID: 1438880 [TBL] [Abstract][Full Text] [Related]
18. Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects. Thomas M; Lumley P Circulation; 1990 Jan; 81(1 Suppl):I53-8; discussion I59-60. PubMed ID: 2136818 [TBL] [Abstract][Full Text] [Related]
19. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275 [TBL] [Abstract][Full Text] [Related]
20. The cleavage of plasmenylethanolamine by phospholipase A2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimulated human platelets. Turini ME; Holub BJ Biochim Biophys Acta; 1994 Jun; 1213(1):21-6. PubMed ID: 8011675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]